Due to the lockdown announced by the South African President, we want to bring the following information to the attention of all participants in SATVI studies.
Professors Mark Hatherill, Tom Scriba, Doctors Simon Mendelsohn & Mbandi have authored an article titled: "Blood transcriptional signatures for tuberculosis testing" appearing in the Lancet Respiratory Medicine.
A paper which UCT’s Professors Mark Hatherill, Robert Wilkinson, Tom Scriba, Drs. Michèle Tameris and Friedrich Thienemann played a key role, has been selected as the best paper of the year for 2019.
Professor Mark Hatherill has co-authored a journal article titled: "Clinical Development of New TB Vaccines: Recent Advances and Next Steps" appearing in the Frontiers in Microbiology journal.
SATVI researchers Professor Tom Scriba and Doctor Stanley Kimbung Mbandi have co-authored an article titled "Immune correlates of tuberculosis disease and risk translate across species" appearing in the Science Translational Medicine journal.
Professor Tom Scriba and Dr Simon Mendelsohn have published a journal article titled: "Making headway towards biosignatures for incipient tuberculosis" appearing in the Lancet Respiratory Medicine.
The Prevention of Recurrence (POR) Consortium has been awarded a substantial grant from the European & Developing Countries Clinical Trial Partnership (EDCTP) which will support a clinical trial in South Africa and Tanzania of a new and promising tuberculosis (TB) vaccine candidate H56:IC31, developed by the Statens Serum Institute (SSI).
Professor Mark Hatherill has co-authored a journal article titled: "Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organisation consultations" appearing in the Vaccine journal.
Dr Michèle Tameris, has co-authored a book chapter titled "Between representing and intervening: Diagnosing childhood tuberculosis during a vaccine trial in South Africa".
Dr Angelique Luabeya has been awarded "C" rating from the National Research Foundation.
The interim Dean of the UCT Faculty of Health Sciences has just announced that SATVI Senior Research Officer, Elisa Nemes has been promoted to Associate Professor.
TB Science Official Press Conference: Watch announcement of final results from M72/AS01E candidate vaccine against tuberculosis (TB) online.